FDA moves to take prescription fluoride drops and tablets for kids off the market

FDA moves to take prescription fluoride drops and tablets for kids off the market


Ferlistockphoto | Istock | Getty Images

The Food and Drug Administration on Tuesday announced it will begin the process of pulling prescription fluoride drops and tablets for children off the market. The supplements are usually given to kids at high risk for cavities.

The federal government and some state legislatures are increasingly drawing attention to what they claim are the risks associated with fluoride, a mineral that’s been used for decades in community water systems, toothpastes and mouth rinses to prevent tooth decay.

Dentists fiercely contest that the harms of fluoride outweigh the benefits.

FDA Commissioner Dr. Marty Makary said in a news release that he’s instructing the agency’s Center for Drug Evaluation and Research “to evaluate the evidence regarding the risks of systemic fluoride exposure from FDA-regulated pediatric ingestible fluoride prescription drug products to better inform parents and the medical community on this emerging area.”

The news release suggested that ingested fluoride can alter a child’s gut microbiome and cause weight gain, thyroid disorders and “possibly decreased IQ.”

U.S. Food and Drug Administration Commissioner Martin Makary attends a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. REUTERS/Nathan Howard

Nathan Howard | Reuters

“The best way to prevent cavities in children is by avoiding excessive sugar intake and good dental hygiene,” Makary said.

The FDA said the evaluation should be completed by Oct. 31.

The new action goes after tablets and drops that contain fluoride. According to the American Dental Association, pediatric dentists can prescribe fluoride supplements to kids living in areas with low fluoride levels in drinking water.

Dr. Meg Lochary, a pediatric dentist in Union County, North Carolina, said she’s been prescribing more of the drops and tablets since county commissioners voted to stop adding fluoride to its water supply last year.

“This is really going to hamper our goal of providing kids with fluoride,” Lochary said. “It’s ridiculous, and it takes away the choice of parents to allow their children to have better dental health. It doesn’t make scientific sense.”

“Unlike toothpaste with fluoride or fluoride rinses, these products are swallowed and ingested by infants and toddlers,” the news release said.

Health Secretary Robert F. Kennedy Jr. has previously referred to fluoride as “industrial waste” on the social media platform X and said on MSNBC that the faster the mineral goes away, the better.

“Ending the use of ingestible fluoride is long overdue,” Kennedy said in Tuesday’s announcement.

Utah and Florida recently banned the addition of fluoride to public water systems. 



Source

CDC takes down more than a dozen webpages on sexual and gender identity, health equity
Health

CDC takes down more than a dozen webpages on sexual and gender identity, health equity

A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other […]

Read More
We’re buying the dip in a health and life sciences stock that has gone down enough
Health

We’re buying the dip in a health and life sciences stock that has gone down enough

We’re buying 20 more shares of Danaher at roughly $180 each. Following Thursday’s trade, Jim Cramer’s Charitable Trust will own 470 shares of DHR, increasing its weighting to about 2.31% from about 2.22%. While Danaher has certainly been one of a handful of problematic stocks in the portfolio, we are stepping into the name here, […]

Read More
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
Health

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial

The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to […]

Read More